Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KW-3357 vs plasma-derived antithrombin for infection-associated DIC
jRCT2080221494Phase 3
- Sponsor
- Kyowa Kirin
- Start
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of antithrombin alfa in disseminated intravascular coagulation (DIC) and sepsis (2 arms), sponsored by Kyowa Kirin.
02
Drugs
antithrombin alfa
03
Conditions
disseminated intravascular coagulation (DIC)sepsis
Beyond the preview
Go deeper on jRCT2080221494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221494.